Risk factors for anti-drug antibody formation to infliximab: Secondary analyses of a randomised controlled trial.
Saved in:
| Title: | Risk factors for anti-drug antibody formation to infliximab: Secondary analyses of a randomised controlled trial. |
|---|---|
| Authors: | Brun MK; Division of Rheumatology and Research, Diakonhjemmet Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Goll GL; Division of Rheumatology and Research, Diakonhjemmet Hospital, Oslo, Norway., Jørgensen KK; Department of Gastroenterology, Akershus University Hospital, Lørenskog, Norway., Sexton J; Division of Rheumatology and Research, Diakonhjemmet Hospital, Oslo, Norway., Gehin JE; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway., Sandanger Ø; Section of Dermatology, Oslo University Hospital, Oslo, Norway., Olsen IC; Department of Research Support for Clinical Trials, Oslo University Hospital, Oslo, Norway., Klaasen RA; Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway., Warren DJ; Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway., Mørk C; Akershus Dermatology Center, Lørenskog, Norway., Kvien TK; Division of Rheumatology and Research, Diakonhjemmet Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Jahnsen J; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Gastroenterology, Akershus University Hospital, Lørenskog, Norway., Bolstad N; Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway., Haavardsholm EA; Division of Rheumatology and Research, Diakonhjemmet Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Syversen SW; Division of Rheumatology and Research, Diakonhjemmet Hospital, Oslo, Norway. |
| Source: | Journal of internal medicine [J Intern Med] 2022 Sep; Vol. 292 (3), pp. 477-491. Date of Electronic Publication: 2022 Apr 26. |
| Publication Type: | Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 8904841 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2796 (Electronic) Linking ISSN: 09546820 NLM ISO Abbreviation: J Intern Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
